Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-Coding Variants in Cancer: Mechanistic Insights and Clinical Potential for Personalized Medicine. | Noncoding RNA | 2021 | 34449663 | PubTator, text mining | PubMed |
| Fluoropyrimidine-Induced Severe Toxicities Associated with Rare DPYD Polymorphisms: Case Series from Saudi Arabia and a Review of the Literature. | Clin Pract | 2021 | 34449540 | PubTator, text mining | PubMed |
| Identification of Novel Metabolism-Associated Subtypes for Pancreatic Cancer to Establish an Eighteen-Gene Risk Prediction Model. | Front Cell Dev Biol | 2021 | 34447748 | PubTator, text mining | PubMed |
| DPYD Exome, mRNA Expression and Uracil Levels in Early Severe Toxicity to Fluoropyrimidines: An Extreme Phenotype Approach. | J Pers Med | 2021 | 34442436 | PubTator, text mining | PubMed |
| Systematic Identification of circRNAs in Alzheimer's Disease. | Genes (Basel) | 2021 | 34440432 | PubTator, text mining | PubMed |
| Population Genetic Difference of Pharmacogenomic VIP Variants in the Tibetan Population. | Pharmgenomics Pers Med | 2021 | 34429635 | PubTator, text mining | PubMed |
| Regulatory Non-coding RNAs for Death Associated Protein Kinase Family. | Front Mol Biosci | 2021 | 34422899 | PubTator, text mining | PubMed |
| Editorial: Population Pharmacogenomics (PGx): From Variant Identification to Clinical Implementation. | Front Genet | 2021 | 34422026 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of circRNA Expression and Construction of "circRNA-miRNA-mRNA" Competing Endogenous RNAs Networks in Bipolar Disorder Patients. | Front Genet | 2021 | 34422020 | PubTator, text mining | PubMed |
| Impact of age and gender on the efficacy and safety of upfront therapy with panitumumab plus FOLFOX followed by panitumumab-based maintenance: a pre-specified subgroup analysis of the Valentino study. | ESMO Open | 2021 | 34416469 | PubTator, text mining | PubMed |
| Mutual Prodrugs of 5-Fluorouracil: From a Classic Chemotherapeutic Agent to Novel Potential Anticancer Drugs. | ChemMedChem | 2021 | 34415107 | PubTator, text mining | PubMed |
| Design, synthesis and biological evaluation of sphingosine-1-phosphate receptor 2 antagonists as potent 5-FU-resistance reversal agents for the treatment of colorectal cancer. | Eur J Med Chem | 2021 | 34411894 | PubTator, text mining | PubMed |
| Pharmacogenomics variants are associated with BMI differences between individuals with bipolar and other psychiatric disorders. | Pharmacogenomics | 2021 | 34410167 | PubTator, text mining | PubMed |
| A novel view on an old drug, 5-fluorouracil: an unexpected RNA modifier with intriguing impact on cancer cell fate. | NAR Cancer | 2021 | 34409299 | PubTator, text mining | PubMed |
| Phylogenetic analysis of combined lobular and ductal carcinoma of the breast. | Mol Med Rep | 2021 | 34396426 | PubTator, text mining | PubMed |
| 5-Fluorouracil Cardiotoxicity: Known But Unknown. | JACC CardioOncol | 2021 | 34396311 | PubTator, text mining | PubMed |
| Analysis of genetic differences between psychiatric disorders: exploring pathways and cell types/tissues involved and ability to differentiate the disorders by polygenic scores. | Transl Psychiatry | 2021 | 34389699 | PubTator, text mining | PubMed |
| Fluorouracil Bolus Use in Infusional Regimens Among Oncologists-A Survey by Brazilian Group of Gastrointestinal Tumors. | JCO Glob Oncol | 2021 | 34383598 | PubTator, text mining | PubMed |
| Evaluation of Low Molecular Weight Cross Linked Chitosan Nanoparticles, to Enhance the Bioavailability of 5-Flourouracil. | Dose Response | 2021 | 34377107 | PubTator, text mining | PubMed |
| A novel machine learning-based approach for the computational functional assessment of pharmacogenomic variants. | Hum Genomics | 2021 | 34372920 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=58